180 related articles for article (PubMed ID: 27522621)
1. Factor VIIa-antithrombin complex: a possible new biomarker for activated coagulation.
Spiezia L; Campello E; Valle FD; Woodhams B; Simioni P
Clin Chem Lab Med; 2017 Mar; 55(4):484-488. PubMed ID: 27522621
[TBL] [Abstract][Full Text] [Related]
2. Association between increased FVIIa-antithrombin complex/FVIIa ratio and pre-eclampsia.
Spiezia L; Visentin S; Radu C; Bon M; Woodhams B; Cosmi E; Simioni P
J Matern Fetal Neonatal Med; 2013 Sep; 26(13):1352-4. PubMed ID: 23488878
[TBL] [Abstract][Full Text] [Related]
3. FVIIa-antithrombin levels in early and late preeclampsia.
Dusse LMS; Godoi LC; Alpoim PN; Gomes KB; Sousa LP; Perucci LO; Lwaleed B; Carvalho MG
Clin Chim Acta; 2017 Nov; 474():67-69. PubMed ID: 28887028
[TBL] [Abstract][Full Text] [Related]
4. Factor VIIa-antithrombin complexes in patients with arterial and venous thrombosis.
Spiezia L; Rossetto V; Campello E; Gavasso S; Woodhams B; Tormene D; Simioni P
Thromb Haemost; 2010 Jun; 103(6):1188-92. PubMed ID: 20431847
[TBL] [Abstract][Full Text] [Related]
5. Tissue factor pathway.
McVey JH
Baillieres Clin Haematol; 1994 Sep; 7(3):469-84. PubMed ID: 7841596
[TBL] [Abstract][Full Text] [Related]
6. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of factor VIIa by antithrombin in vitro, ex vivo and in vivo: role of tissue factor and endothelial cell protein C receptor.
Vatsyayan R; Kothari H; Mackman N; Pendurthi UR; Rao LV
PLoS One; 2014; 9(8):e103505. PubMed ID: 25102166
[TBL] [Abstract][Full Text] [Related]
8. Tissue factor-dependent pathway in severe preeclampsia revisited: a Brazilian cohort study.
Dusse LM; Godoi LC; Gomes KB; Carvalho Md; Lwaleed BA
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):436-40. PubMed ID: 26765308
[TBL] [Abstract][Full Text] [Related]
9. Factor VIIa-AT Complex Is an Independent Prognostic Marker of Disseminated Intravascular Coagulation.
Lee JH; Gu J; Kim HK
Ann Clin Lab Sci; 2021 Jul; 51(4):546-551. PubMed ID: 34452894
[TBL] [Abstract][Full Text] [Related]
10. Heparin affinity of factor VIIa: implications on the physiological inhibition by antithrombin and clearance of recombinant factor VIIa.
Martínez-Martínez I; Ordóñez A; Pedersen S; de la Morena-Barrio ME; Navarro-Fernández J; Kristensen SR; Miñano A; Padilla J; Vicente V; Corral J
Thromb Res; 2011 Feb; 127(2):154-60. PubMed ID: 21126754
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor pathway inhibitor inhibits aortic smooth muscle cell migration induced by tissue factor/factor VIIa complex.
Sato Y; Asada Y; Marutsuka K; Hatakeyama K; Kamikubo Y; Sumiyoshi A
Thromb Haemost; 1997 Sep; 78(3):1138-41. PubMed ID: 9308767
[TBL] [Abstract][Full Text] [Related]
12. Factor VIIa-antithrombin complexes in patients with non-neoplastic portal vein thrombosis with and without cirrhosis.
Rossetto V; Spiezia L; Senzolo M; Rodriguez K; Gavasso S; Woodhams B; Simioni P
Int J Lab Hematol; 2013 Feb; 35(1):101-5. PubMed ID: 22958499
[TBL] [Abstract][Full Text] [Related]
13. Decreased plasma levels of activated factor VII in patients with deep vein thrombosis.
Schut AM; Meijers JC; Lisman-van Leeuwen Y; van Montfoort ML; Roest M; de Groot PG; Urbanus RT; Coppens M; Lisman T
J Thromb Haemost; 2015 Jul; 13(7):1320-4. PubMed ID: 25891834
[TBL] [Abstract][Full Text] [Related]
14. Interaction of activated factor VII and active site-inhibited activated factor VII with tissue factor.
Sørensen BB; Rao LV
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S67-71. PubMed ID: 9819031
[TBL] [Abstract][Full Text] [Related]
15. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis.
Mackman N; Tilley RE; Key NS
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1687-93. PubMed ID: 17556654
[TBL] [Abstract][Full Text] [Related]
16. On the mechanism of inhibition of tissue factor pathway by the synthetic pentasaccharide during coagulation of human plasma.
Gerotziafas GT; Elalamy I; Depasse F; Chakroun T; Bara L; Arzoglou P; Samama MM
Blood Coagul Fibrinolysis; 2003 Oct; 14(7):633-8. PubMed ID: 14517487
[TBL] [Abstract][Full Text] [Related]
17. Direct Amplification of Tissue Factor:Factor VIIa Procoagulant Activity by Bile Acids Drives Intrahepatic Coagulation.
Baker KS; Kopec AK; Pant A; Poole LG; Cline-Fedewa H; Ivkovich D; Olyaee M; Woolbright BL; Miszta A; Jaeschke H; Wolberg AS; Luyendyk JP
Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):2038-2048. PubMed ID: 31412737
[TBL] [Abstract][Full Text] [Related]
18. Determination of the kinetic constants of tissue factor/factor VII/factor VIIA and antithrombin/heparin using surface plasmon resonance.
Björquist P; Boström S
Thromb Res; 1997 Feb; 85(3):225-36. PubMed ID: 9058497
[TBL] [Abstract][Full Text] [Related]
19. The various assays for measuring activity states of factor VIIa in plasma and therapeutic products: Diagnostic value and analytical usefulness in various pathophysiological states.
Amiral J; Dunois C; Amiral C; Seghatchian J
Transfus Apher Sci; 2017 Feb; 56(1):91-97. PubMed ID: 28089408
[TBL] [Abstract][Full Text] [Related]
20. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
Norledge BV; Petrovan RJ; Ruf W; Olson AJ
Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
